How we diagnose neutropenia in the adult and elderly patient.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4077072)

Published in Haematologica on July 01, 2014

Authors

Jan Palmblad1, Carlo Dufour2, Helen A Papadaki3

Author Affiliations

1: Department of Medicine and Hematology, The Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden, and SWG on Granulocytes and Monocytes of the EHA Jan.Palmblad@ki.se.
2: Clinical and Exprimental Haematology Unit, G.Gaslini Children's Hospital, Genova, Italy and SWG on Granulocytes and Monocytes of the EHA.
3: Department of Hematology, University of Crete Medical School, Heraklion, Greece and SWG on Granulocytes and Monocytes of the EHA.

Articles cited by this

Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Am J Hematol (2011) 1.58

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57

Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematology Am Soc Hematol Educ Program (2012) 1.45

Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol (1991) 1.35

Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood (1998) 1.27

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica (2013) 1.26

Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J Exp Med (2013) 1.21

Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface. Leuk Res (2007) 1.16

Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol (2009) 1.12

Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol (2011) 1.10

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis. Med Oncol (2008) 0.95

Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood (2002) 0.93

Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia. Expert Rev Hematol (2008) 0.92

How to approach neutropenia in childhood. Pediatr Rev (2013) 0.90

Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol (2005) 0.89

Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Pediatr Blood Cancer (2011) 0.86

External quality assessment of human neutrophil antigen (HNA)-specific antibody detection and HNA genotyping from 2000 to 2012. Vox Sang (2013) 0.81